# 2025-21192: DEA Eyes Noramco's Bid to Manufacture Bulk Opioids

2025-21192, Bulk Manufacturer of Controlled Substances Application: Noramco, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-11-26, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 26, 2026. Such persons may also file a written request for a hearing on the application on or before January 26, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-21192
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-21192
- Title: Bulk Manufacturer of Controlled Substances Application: Noramco
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 54375
- Published: 2025-11-26
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 26, 2026. Such persons may also file a written request for a hearing on the application on or before January 26, 2026.
- Comments close: 2026-01-26
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

DEA Eyes Noramco's Bid to Manufacture Bulk Opioids

## Summary

Noramco wants to become a big-time maker of certain controlled drugs, including marijuana and some painkillers. People and companies already registered can share their thoughts or ask for a hearing by January 26, 2026. This move could affect drug supply chains and involves careful government review, but no direct costs are mentioned yet.

## Abstract

Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-21192 on federalregister.gov](https://www.federalregister.gov/documents/2025/11/26/2025-21192/bulk-manufacturer-of-controlled-substances-application-noramco)
- [2025-21192 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-11-26/pdf/2025-21192.pdf)

## Related
- [Previous: 2025-21191, Importer of Controlled Substances Application: Noramco](https://policyrisk.com/federal-register/2025-21191)
- [Next: 2025-21193, New Postal Products](https://policyrisk.com/federal-register/2025-21193)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-21192 (as of 2026-06-08).
